Sponsored by:
Department of Medicine, Faculty of Medicine
University of Toronto and
Princess Margaret Cancer Centre

The 2019 Multiple Myeloma Day Conference is now sold out.


  • Enhance the management of relapsed myeloma through multiple lines of therapy
  • Introduce the concept of immunotherapies in the treatment of myeloma
  • Improve the understanding of the diagnosis and treatment of MGRS


At the end of the program participants will be able to:

  • Identify to select and sequence combination therapies, use rationale consideration of patient, disease, and therapy characteristics
  • Assess, risk-stratify, and treat myeloma patients using novel immune-based regimens, including CAR-T cells
  • Ascertain on how to differentiate features of various disease entities that fit under the category of MGRS and develop treatment strategies, despite the lack of data

Target Audience

Community health practitioners including physicians, nurses, pharmacists, trainees, and other health care providers who are involved in the care of patients with plasma cell disorders will find this program of benefit.